Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Tirzepatide clinical trial results The SURMOUNT-1 trial tested tirzepatide in adults with obesity or overweight without type 2 diabetes
International Journal of Endocrinology
We included products from a range of manufacturers in different formats tablets, capsules, gummies and sprays and at a variety of price points to reflect the options available
Call 911 if your symptoms feel life threatening or if you think youre having a medical emergency
Each step of your journey is monitored to ensure the highest standard of safety and effectiveness , and were here to adjust your plan as needed
The clinical insights from these studies demonstrate how our portfolio may offer more tailored, individualised treatment options for people living with obesity. The data presented on Roches obesity assets include: Enicepatide (CT-388) : Late-breaking data from the Phase II (CT388-103) study will highlight clinical weight loss outcomes from investigational enicepatide in people living with overweight/obesity
US$ 20.62
US$ 20.21
US$ 22.39
